Immunization impact is not always visible in the way we expect important things to be visible. Sometimes it looks like nothing at all. It looks like a child who did not get sick. A classroom that stayed full through winter. A mother who did not spend three weeks watching her infant fight a fever that should never have been possible in the first place.
I think about a woman I will call Patience, a patient’s grandmother I met during a ward round early in my clinical training. She was in her seventies, small and very precise in the way she spoke, and she had come to sit with her granddaughter who had a routine respiratory infection and would be home within the week.
At some point, she mentioned that she had lost two children before her third birthday to diseases she named without drama, the way you name things you have made a long peace with. Then she looked at her granddaughter in the hospital bed, reading a magazine, entirely unbothered, and said something I have carried since. She said: “that child does not know what she has been spared.”
Fifty Years, One Programme, and the Numbers That Still Take the Breath Away
The Expanded Programme on Immunization, launched by the World Health Organisation in 1974, began with six vaccines targeting six diseases: diphtheria, tetanus, pertussis, measles, poliomyelitis, and tuberculosis. At the time of its founding, routine immunization reached fewer than five percent of children in low and middle income countries. The immunization impact of those early years was constrained not by the science but by the infrastructure, the cold chains, the community trust, the trained personnel, and the political will required to move a vaccine from a laboratory to the arm of a child in a rural district with no paved road and no reliable electricity.
What happened over the following five decades is one of the most significant and least celebrated achievements in the history of human health. Global immunization coverage climbed from that five percent baseline to above eighty percent for most essential vaccines. Smallpox was eradicated entirely in 1980, the first and still only human disease to be fully eliminated through vaccination. Polio, which once paralysed hundreds of thousands of children annually, has been reduced to a handful of cases in the final two countries where transmission continues. The immunization impact on child mortality alone is estimated at more than 150 million lives saved over the programme’s fifty-year history.
That number requires a moment. One hundred and fifty million lives. Not lives improved or outcomes shifted or hospitalisations averted. Lives. People who exist, who grew up, who had children of their own, because a vaccine was available and a health worker got it to them. The immunization impact embedded in that figure is not a policy achievement. It is a civilisational one. And it sits largely unacknowledged in the broader public conversation about what collective health investment can actually accomplish.
What the EPI Actually Changed on the Ground: Communities, Children, and the Equity Question
Immunization impact has never been distributed evenly, and any honest account of the EPI’s fifty years has to hold both the extraordinary progress and the persistent gaps in the same hand. The programme transformed childhood survival in low and middle income countries in ways that reshaped entire demographic trajectories. When child mortality falls, birth rates eventually follow. When families can reasonably expect their children to survive to adulthood, the calculus around family size, investment in education, and women’s participation in economic life shifts in ways that compound across generations.
The measles vaccine alone carries an immunization impact that extends well beyond the prevention of measles. Measles infection causes a form of immune amnesia, stripping the body of antibodies it has built against other pathogens over months or years, leaving children vulnerable to a cascade of secondary infections for up to three years after recovery. Preventing measles does not only prevent measles. It preserves the entire immune history a child has accumulated. The communities where measles vaccination reached high coverage saw reductions in child deaths from multiple causes, not only from measles itself, an effect that researchers spent years unpacking and that is now well established in the immunization impact literature.
The equity dimension of the EPI’s history is where the story becomes more complicated and more important. The programme was designed explicitly to reach children who had been excluded from the benefits of existing health infrastructure, children in rural and remote communities, in conflict-affected regions, in the lowest income households in the lowest income countries. In its early decades, it made significant progress against that mandate. Gavi, the Vaccine Alliance, established in 2000, extended that reach further by negotiating lower prices for newer vaccines and funding immunization programmes in the world’s poorest countries. The immunization impact of those investments has been documented extensively.
What remains is the last mile problem that every immunization programme in every generation has eventually encountered. The children who are hardest to reach are not evenly distributed. They cluster in specific geographies, specific communities, and specific social categories. Children of migrant workers. Children in informal urban settlements. Children in communities with accumulated distrust of health systems built from historical experience rather than misinformation. Reaching these children requires more than supply. It requires trust, and trust requires time and consistency and the kind of presence that a campaign visit every two years cannot build.
The Human Architecture Behind Every Vaccine: Workers, Families, and the Moments Nobody Photographs
Immunization impact does not deliver itself. Behind every percentage point of coverage there is a human chain that most recipients never see and few programme reports adequately honour. Community health workers who carried vaccines in cold boxes across distances that made the logistics of the thing seem impossible. Local leaders who vouched for a programme to a community that had reason to be cautious. Mothers who brought their children back for the second dose, and the third, because someone had explained clearly what the schedule was and why it mattered. Fathers who took a morning from work to carry an infant to a clinic that was not close.
The immunization impact literature tends to measure outcomes at the population level, which is appropriate for the purposes of policy and planning. But the mechanism of that impact is always individual. It is always a specific person deciding, on a specific morning, to participate in a system that is asking something of them in exchange for something they cannot yet see. That decision, made by hundreds of millions of parents across five decades, is the actual architecture of what the EPI built. The vaccines were the tools. The human choices were the construction.
I have thought about Patience many times since that ward round. About what she carried in the matter-of-fact way she named her losses. About what it meant that she was sitting in a hospital watching her granddaughter read a magazine, bored and recovering and entirely unaware of the alternative. That unawareness is, in a specific way, the point. Immunization impact is most complete when it is most invisible. When the disease is so rare that the generation growing up has no framework for its weight. When the grandmother is the only one in the room who remembers.
That is what fifty years built. Not just the absence of disease. The absence of the memory of it. The freedom of a child who does not know what she has been spared. Patience knew. And she sat with her granddaughter in that room with the quiet satisfaction of someone watching a future that her own children never got to have.
The EPI turns fifty this year. It deserves more than a press release.
Vaccination remains one of the most effective tools in preventive healthcare. If you are unsure about your own immunization status or that of your child, please speak with a qualified healthcare professional or visit your nearest health facility.
